Tag Archive for: #BJUI

Posts

Urologist as the Go-to Adrenal Surgeon?

What do Galen, da Vinci, and Vesalius have in common? All three, in all their detailed description of human anatomy, failed to note the existence of the adrenal glands. In fact, it was Bartholomeus Eustachius (yes, the one of the “tube”) who in 1563 was the first to document the glands’ existence. Meanwhile, it took another three centuries for Thomas Addison to recognize the physiologic importance of the adrenals. Soon thereafter, Charles Brown-Sequard, who appears to have toyed not only with spinal cords, removed both adrenals from a dog, thus proving that the glands were critical to life.

Notwithstanding the adrenals being a source of major human ailments, the glands and their pathology to this day often remain unnoticed. For instance, a study in the Harvard Vanguard healthcare system revealed that >80% of adrenal lesions do not receive adequate evaluation. Meanwhile, nearly 20% of adrenal incidentalomas potentially represent surgical lesions. Indeed, perhaps due to their understated anatomic prominence or more likely due to the embryologic origins that are distinct from the urinary or gastrointestinal tracts, the adrenal glands largely remain “orphans” in the surgical arena. Yes urologists, surgical oncologists, and more recently subspecialists known as endocrine surgeons manage and operate on the adrenal glands; nevertheless, referral patterns and expertise vary, and, arguably, no surgical specialty has consistently “parented” these organs.

In this lies a great opportunity.  Today’s urologists are ideally positioned to take the reigns on the surgical management of the adrenals. With the urologist’s advanced minimally invasive surgical skills, comfort with both retroperitoneal anatomy and surgical approaches to retroperitoneal organs, it is only natural that the evaluation and surgical management of adrenal disorders evolve and remain in the domain of urologic surgeons.

Nevertheless, a technical skillset in removing an adrenal should not be mistaken for adequate expertise in management of its pathology. In order for urologists to position ourselves as surgical leaders in the adrenal space, fluent knowledge of adrenal pathophysiology and appropriate evaluation is paramount. Nevertheless, “know-how” of adrenal management is infrequently mastered during urologic training. In my experience, many trainees and practicing urologists are somewhat overwhelmed by the complexity of adrenal pathophysiology and are often unsure how to distill the large volume of information they’ve learned for standardized examinations into practical knowledge. For instance, expertise on how to appropriately evaluate a referral for a newly diagnosed adrenal lesion is often lacking. Such lack of expertise potentially leads to overtreatment of some patients and undertreatment of others.

As the field moves forward, we must better educate our trainees and practicing urologists on the practical nuances of surgical management of the adrenals. The AUA Core Curriculum effort is a great start. However, a brief course at the AUA and/or EUA for practicing urologists is urgently needed.

As such, the close anatomic and physiologic relationship of the adrenals to the kidney positions urologists as the most appropriate surgical specialists for treatment of surgical adrenal disorders. However, leadership in the surgical adrenal space must be founded not only on technical skills, but also on clinical fluency in appropriately evaluating, selecting, and medically managing patients with adrenal neoplasms and disease. Tremendous opportunities on bridging the knowledge gap in management of surgical adrenal disorders exist and, potentially, can be solved by formal courses at national meetings.

 

Dr Alexander Kutikov, MD is an Associate Professor of Urologic Oncology at Fox Chase Cancer Center, Philadelphia, USA. @uretericbud

 

Comments on this blog are now closed.

 

What’s the diagnosis?

Test yourself against our experts with our weekly quiz.

You can type your answers here if you want to compare with our answers, or just click the ‘submit’ button below.

[wpsqt name=”Picture Quiz of the Week 23-1-13″ type=”quiz’ label=’

Click here for more Picture Quizzes

The Flaws of the PIVOT Study of Radical Prostatectomy versus Observation; Don’t Give up on PSA Just Yet.

A recent editorial in the BMJ by Christopher Parker (Treating prostate cancer. BMJ 2012; 345: e5122) uses the “best available evidence” from the PIVOT study (Wilt TJ, et al) to argue the case for watchful waiting for low risk prostate cancer and question the need to diagnose the condition at all. Unfortunately the PIVOT trial was marred by a number of serious flaws that should make us doubt its conclusions.

The original design of the PIVOT trial included a randomisation of 2000 patients to surgery or observation (Prostate cancer, uncertainty and a way forward. NEJM 2012; 367: 270-1). Unfortunately, this goal was not achieved; the design was modified to justify a randomization goal of only 740 patients. Median survival was assumed to be 15 years in the original study design and 10 years in the updated version. If the median survival of 12 years in the study’s observation group is taken and 7 years for enrollment and 8 years of follow-up assumed, the sample requires 1200 patients in order to detect a 25% relative reduction in mortality with 90% power and a two-sided alpha level of 0.05. With an actual enrollment of only 731 patients, the study was consequently underpowered to detect this relatively large clinical effect. The wide 95% confidence interval around the hazard ratio for death in the treatment group illustrates this point. A relative increase of 8% to a relative reduction of 29% in the risk of death in the prostatectomy group, as compared with the observation group, cannot be excluded with 95% confidence. Only 15% of the deaths were attributed to prostate cancer or its treatment.

Although a “life expectancy of at least 10 years” was an entry criterion, by 10 years almost half the participants had died, leaving only 176 men in the surgery group and 187 in the observation cohort, and by 15 years only 30% were alive. The investigators therefore did not recruit healthy men who would be the normal candidates for surgery and randomize them to observation; instead they recruited elderly and co-morbid men with very limited life expectancy and randomised them to surgery (with one fatality!). Furthermore, the finding that one fifth of patients did not adhere to the assigned treatment further reduces the ability of the trial to discern a treatment effect.

Prostate cancer is a slowly progressive condition which eventually, and after many years, results in a painful death from metastases in a significant number of patients, unless mortality from other causes supervenes. Radical prostatectomy, now usually performed minimally invasively with robotic assistance (Goldstraw MA, et al), prevents disease progression in >80% of well-selected cases. We appear to manage localised prostate cancer in a much more holistic way than our American colleagues and MDT decision-making and robust active surveillance programmes have enhanced this. Others were also outraged by the Parker editorial and the intrinsically flawed results of the PIVOT study should definitely not encourage us to turn our backs on a disease that kills more than 10,000 men per annum in the UK and hundreds of thousands more worldwide.

 

Roger Kirby, Ben Challacombe and Prokar Dasgupta
The Prostate Centre, London W1G 8GT and Guy’s Hospital, King’s College London, King’s Health Partners

 

Comments on this blog are now closed.

 

BJUI and The Urology Foundation at 10 Downing Street

Last night, I was delighted, along with other members of the BJUI Editorial Board, to attend a reception for The Urology Foundation at Number 10 Downing Street, hosted by the UK’s “First Lady” Samantha Cameron.

The reception was attended by many eminent urologists as well as a number of well-known personalities.

The primary aim of the reception was to raise awareness for the Foundation and its work and all of us at the BJUI are happy to help in that aim.

Prokar Dasgupta, Editor-in-chief

 

 

 

The Urology Foundation issued the following Press Release:

TUF Downing Street Reception hosted by Samantha Cameron

On Tuesday 22nd January 2013, Samantha Cameron kindly hosted a reception at No 10 Downing Street, for The Urology Foundation.

The Urology Foundation is the only UK charity that covers all urological diseases. It aims to improve the diagnosis, choice and care of patients with urological diseases by supporting pioneering research and providing specialist training to improve the skills and effectiveness of UK health professionals working in urology.

Around 120 dedicated supporters and friends gathered together in the Terracotta and Pillared Rooms, to celebrate The Foundation and the exceptional work it undertakes. Speeches were given by Samantha Cameron as well as the Hon Secretary of The Foundation, the esteemed Professor Roger Kirby, who announced an exciting new Bladder Cancer Awareness campaign for 2013.

Kindly showing their support were, amongst others, Ronnie Corbett CBE who is embarking upon a radio campaign for The Foundation, Private Eye editor Ian Hislop and actors, Jemma Redgrave, Vanessa Kirby and Douglas Booth.

 

Comments on this blog are now closed.

No Heat in the Desert

I am blogging again my friends. Blogging is freedom in the 21st Century; the modern equivalent of standing on a soapbox in Speakers’ Corner in London. Still, only old people write formal blogs now, young people microblog. They use Twitter, Reddit, Tumblr, or Instagram. Blogging is no more modern than an open radical prostatectomy is sexy; actually its old-fashioned and beneath me. Still, I like it. And more importantly, it gives me an easy outpost to write about urology in an informal manner. So off we go – I am going to give blogging its sexy back.

For the past 20 years, my department at the University of Pittsburgh has sponsored and developed a course to aid board-eligible urologists tackle the oral urology boards (or part 2). We locate the course in Scottsdale, Arizona in Maricopa County. Maricopa county was recently in the news for having a controversial sheriff cited by the Department of Justice for engaging in a pattern or practice of unconstitutional policing” and had “a chronic culture of disregard for basic legal and constitutional obligations.” I use this to scare the candidates into submission. If they misbehave I simply release them into the streets and lock the hotel door. Good luck out there!

 

 

 

I have been the supreme leader – or king as my followers call me – of the course for the past 3 years. The onus is on me to develop, curate, prod, shape, and refine the protocols for the exam. Naturally, I do a great job. This year we had an active hashtag following the course #GUMOCK13.

The urotwitterati were in heavy attendance from Dr. Loeb (@LoebStacy) gracing us with her fashionista presence, and the braintrust of Drs. Morgan and Kutikov (@wandering_gu and @uretericbud) were also there. Even my colleague Dr. Averch (@tdave) made a good twitter presence (a breakthrough). The break dancing and karaoke crooner Prof. Cooperberg (@cooperberg_ucsf) also had a defining presence.

The highlight for me was the profound talk from our guest motivational speaker Wayne Sotile. Just calling yourself a motivational speaker makes me yearn for a shotgun. As a non-believer I was thoroughly entertained and – more importantly – actually learned a great deal about the work/family balance. Some highlights with (tongue-in-cheek) twitter reactions as hyperlinks:

  1. It is not the absolute hours you work that impacts your family life it’s the mood you bring home with you. Tweets here….
  2. We work in a high-demand and low-control environment – that is the ultimate stressful situation. Tweets herehere
  3. Levels of intimacy plummet until the 10 year mark in your marriage then they increase markedly. Tweets….here

The course ended with overall good reviews. The candidates appeared well-prepared, fine young doctors and I was impressed. Still – with a fail rate hovering at 11% the stress levels are high for these physicians. It did not help that the hotel seemed unable to provide the comfort we all desire after working all day and drinking all night – a hot shower. Over 50% of the attending participants had to contend with a cold or tepid shower because of a failed water pump that the hotel scampered to fix. I didn’t mind the dishevelled hippie hair look and – luckily – it appeared to keep the Sheriff’s department at bay.

 

 

Benjamin Davies is Assistant Professor of Urology at the University of Pittsburgh; Program Director, Urologic Oncology Fellowship and Chief, Division of Urology Shadyside Hospital. His views are his own. @daviesbj

 

Comments on this blog are now closed.

“SEER-UROLOGY”

“It’s a gold mine!” said someone to me once about the Surveillance, Epidemiology, and End Results (SEER).

Most of you are probably aware of the existence of this large observational population-based cohort of the National Cancer Institute in the United States. The quality of the SEER’s data collection and the immense pool of information on patient socio-demographics, morphology, therapeutic treatment and long-term follow-up for vital status (and more) are nothing short of extraordinary.

Officially, the SEER was developed to monitor cancer trends and data on cancer incidence, extent of disease, treatment and survival.

Unofficially, the SEER has become more or less a funhouse for research scientists, comprising urology investigators as well, probably because the advantages of the SEER database are so appealing:

– it is readily available (click and download);

– the number of patients, even after excluding a bunch of people, is colossal (“Wow! You did all those partial nephrectomies?” someone asked me at the American Urological Association two years ago);

– the findings are publishable (except at one famous journal, who rejects all SEER submissions without external review);

– It’s free! – unless you want to use the SEER Medicare-linked database, in which case, a few robotic-assisted prostatectomies performed by a co-investigator can easily cover the cost (thanks Quoc).

Yet, many individuals within the urological community remain skeptical, borderline aversive towards studies relying on population-based cohorts, such as the SEER database, or the

Nationwide Inpatient Sample (NIS), or the Florida Hospital Inpatient Datafile, to name a few.

At first I didn’t understand why. Because some of the highest quality, most well-designed, and widely cited studies that were published in high-end journals like the New England Journal of Medicine, the Journal of American Medical Association, and the Lancet actually originated from large population-based databases.

But then I realized that – put aside a few people who are just old and bitter – some of these aversions towards studies relying on observational cohorts could be because there is quite a bit of redundant, inconsistent, trivial junk out there that has been published using population-based cohorts like the SEER.

In a recent letter of correspondence in JAMA, Quoc and I wrote a little piece that could be considered as a potential remedy against the issue at hand.  Whereas some may think that the proposed principles appear excessively strict, we personally believe that it can help regulate the prevalent redundancy, reduce discrepancies, and improve the overall quality of the work within population-based reports. Well, at least that is what we think the population-based research community should aim for. Until then…the clock is ticking!

 

Maxine Sun is a urologic-oncological research scientist and co-director of the Cancer Prognostics and Health Outcomes Unit in Montreal. @maxinesun

 

Comments on this blog are now closed.

 

Humour and the doctor-patient interaction: thoughts from a urological perspective

Marni Basto

The Urologist cursed with contempt at his finger in the air, discussing with me his practice of prostatic massage, “I’ve had to learn to use my left pointer, the right one developed osteoarthritis”. A moment of silence, then laughter!

From medical school I observed the different ‘phenotype’ of consultant between the specialties and noted the way certain personality types appeared attracted to particular fields. Whilst plastic surgeons displayed a dichotomy of perfectionism and relaxed demeanor, Urologists always struck me as the happy bunch. Witty, personable and sharp with the ability to laugh at themselves and the very nature of the specialty. The sensitive side of some urological conditions makes the doctor-patient interaction and rapport building all the more important. Humour has the ability to enhance communication, break down barriers, develop a therapeutic alliance and improve patient satisfaction. An Urologist’s judicious use of humour may provide the impetus to enter sensitive and personal areas of discussion.  However used without caution can be counterproductive and jeopardise the relationship. As a student and resident I recall some inspiring but also abysmal attempts at humour in the clinical encounter which made me think about how best we can utilise this powerful tool.

Interestingly, the etymology of humour is medically derived from Latin meaning ‘moisture’ or ‘fluid’. It was believed the proportion of four bodily fluids: Blood, phlegm, yellow bile and black bile each conferred unique personality traits and temperament. An imbalance of humours therefore made a person eccentric or odd. With time the word came to refer to those who provoked laughter at the oddities and incongruities of life. Clearly the ancient philosophers were not Urologically inclined –  Two shades of bile?!

Freud noted that the best humour often stems from taboo topics which is perhaps why Urology lends itself well to its use in a clinical encounter.   It’s a tool that can be used by both doctors and patients as a coping mechanism and to reduce the effect of stress.

Here this was exemplified, as I overheard an Urologist discussing with his British patient the TRUS Biopsy he was about to have,

Patient: ‘I am a little nervous, do you think I’ll feel it at all?

Urologist: ‘No, no, you’ll be off to sleep. But if you did it looks and feels somewhat like the Gherkin in the London Skyline……. Hideously awkward!’

To which the patient almost fell off the bed in tears of laughter. Granted however the Urologist had known this patient for many years and was ‘au fait’ with his style of humour. Another important learning point. Lack of familiarity can cause humour to be ineffective particularly at first consult or in cross cultural encounters. Although we’d say most aspects of humour are broadly trans-societal, one can’t always assume. If unsure always err on the side of caution.

Patient-generated humour can be the most bonding of all in its ability to empower the patient and unite a medical team. ‘Nota bene dic doc’ a recent article published in the Canadian Urological Association Journal by Associate Professor Nathan Lawrentshuck describes a patient who strategically placed a poem in his underpants for the team to see prior to his prostatectomy. This is well worth accessing for the full read however ends along the lines of; “But my sex life is on the upwards curve, So hey there buddy can you spare a nerve?” This had the effect of uniting the team to achieve the best outcome for the patient, who was rapt with the positive response from the staff.

Developing this type of bond with your patients can be extremely rewarding for everyone involved and again Urology lends itself well to this interaction given patients are commonly followed up for years. It takes a while however to get to this point for example;

Patient to long term Urologist regarding recurrent bouts of renal colic: “Can’t you just prescribe me some cyanide?” 

Urologist: “I would except it’d be bad for business – I wouldn’t get any more follow-up visits out of you”. Both laugh!

In a world that is time poor and litigation crazy, humour also can be a tool to ameliorate risk. A US study looked at practice behaviours that helped to decrease the risk of a malpractice suit. It was found that physicians who’d never had a claim against them laughed more and used humour more often during visits. Perhaps this shows once and for all that laughter really is the best medicine!

So for this bunch of plumbers the opportunities for toilet humour are pretty damn concentrated, here’s a great reference! Some food for thought;

• Humour is a useful vector for developing a doctor-patient relationship and can lead to a more rewarding interaction for both parties.

• Humour is best developed with familiarity.

• Learn to use humour to create a healing environment.

• It may assist in entering sensitive areas of discussion.

• Judicious use of humour is appropriate always.

• Externally-focused humour (E.g. weather, parking) carries the least risk in miscommunication and is a good starting point.

• Beware of cross cultural barriers.

• Sole reliance on humour in an interaction can be perceived as flippant.

• Humour may assist in decreasing the risk of malpractice suits.

So even if you’re a medical student, like I was, whose only knowledge of Urology is the great catfish Candiru that swims up the urine stream against gravity and lodges in the urethra; feel free to share any comments, words of wisdom and your own funny experiences for everyone’s enjoyment below.

 

Marnique Basto is a Uro-Oncology Research Fellow at Peter MacCallum Cancer Centre, Melbourne, Australia.

@DrMarniqueB

 

Comments on this blog are now closed.

 

Anaesthesia for robotic-assisted laparoscopic radical prostatectomy

Richard MoreyHere’s my technique for anaesthetising patients for robotic-assisted laparoscopic radical prostatectomy and I’d be interested to hear any thoughts, comments and ideas.

Pre-op. I try to fast the patients for as short a time as possible and also include pre-operative carbohydrate loading. This is in line with Enhanced Recovery After Surgery (ERAS) Guidelines for major bowel surgery and has been shown to reduce the negative nitrogen balance that occurs following major surgery. I use 200ml cartons of Polycal, which is clear and non-particulate, prescribed 12 and 3 hours pre-operatively. Clear fluids are encouraged up to 2 hours pre-op as this improves gastric emptying and minimises pre-operative dehydration.

Intra-op. I use a mixed technique of both general and regional anaesthesia. The general consists of a fairly standard technique with a Propofol induction and maintenance with Desflurane and a Remifentanil infusion. To reduce post-operative nausea and vomiting I use ondansetron, cyclizine and dexamethasone. The regional part is a spinal anaesthetic using 0.5% Hyperbaric Bupivacaine with additional intrathecal Diamorphine. Regional anaesthesia has been shown to reduce peri-operative DVT formation, probably by blocking sympathetic activity and improving blood flow through the legs, it also produces profound muscular relaxation enabling better pelvic vision and easier insufflation. In addition there is some evidence that appears to suggest regional anaesthesia may reduce the recurrence rate of prostate cancer. As the patients are positioned in a steep trendelenberg they are all intubated and ventilated with a small amount of additional PEEP to reduce pulmonary atelectasis.

Post-op. Intrathecal diamorphine usually provides 12-14 hours of good quality post operative analgesia. Intrathecal opiates act locally producing segmental analgesia and therefore do not produce the systemic side effects to the same degree as intravenous opiates. The ondansetron given peri-operatively may reduce the incidence of opiate induced pruritus as well as acting as an excellent antiemetic. Additional analgesia will be required but usually paracetamol and ibuprofen are sufficient. It is unusual for patients to require any additional stronger opioid medications and this is helpful in ensuring that gastric stasis and reduced gut motility do not occur. This enables the patients to be rapidly progressed on to a light solid diet that in turn further reduces the occurrence of a post-operative ileus.

Fluid Management. Using this starvation policy, patients should commence their surgery with only a minimum degree of dehydration. Remifentanil produces an extremely cardio-stable anaesthetic and with the patients being head down peri-operative hypotension is unusual.  Should this however occur blood pressure should be maintained with the judicial use of vasopressors and fluid if necessary. Post-operative urine output can be maintained if required with plasma expanders and diuretics.

 

Richard Morey qualified from MHMS in 1987 and has been a Consultant Anaesthetist in SE London since 1997. His particular interests are ERAS/ Laparoscopic Surgery along with ENT and Difficult Airways.

@morphthegasman

 

Comments on this blog are now closed.

The X-Factor, Reality TV, and Live Surgery Demonstration

Declan theatreMy first suggestion to my wife was that I enter Pop Idol with my modified, radiation-bashing rendition of American Pie (chorus “bye bye brachytherapy seeds“). She quickly retorted “DIVORCE! YOU CANT SING!” I begrudgingly agreed. Then Britain’s Got Talent came along and I saw an overweight Greek father and son duo, Stavros Flatley, prance around the stage bare-chested, dancing to some traditional Greek music and I thought “YES! There is hope!” I put on Riverdance, grabbed my then three-year-old son and started teaching him the basics of an Irish jig. I pleaded with my wife to allow us enter the X Factor (or whatever reality TV show was auditioning at that time), but she again screamed “DIVORCE!”. It appeared my hopes of finding fame on reality TV were dashed forever (although I expect Masterchef might be interested in my prowess on the BBQ – Murphy’s Marvellous Marinade on a whole eye fillet deserves a wider audience).

At about that time, the vogue of having live surgery demonstrations featuring at clinical meetings was really gaining momentum. The World Robotic Symposium, European Robotic Urology Symposium, European Society for Urological Technology section meeting at the EAU, Challenges in Laparoscopy & Robotics and others, were all featuring live surgery demonstrations as a prominent part of their scientific program. These sessions feature enormous high-definition screens, 3D broadcast in some circumstances, parallel operating rooms, and live interaction with the surgical team, and have proved enormously popular with audiences and sponsors alike. In fact, without live surgery, some of these meetings would be quite dull –there is certainly a commercial value in featuring live surgery as part of the program as is demonstrated by the huge numbers attending these sessions. Whether it is the lure of seeing world-famous surgeons perform robotic prostatectomy, partial nephrectomy or various types of salvage surgery, or the ever-present possibility of seeing a complication and its management, there is a blood-lust which surgical audiences have for this type of entertainment, sorry – education, and which is being met by the organisers of urology conferences. A merry band of surgeon-entertainers roam the world turning up at these conferences with their entourage of assistants and scrub nurses, and turning on the charm for the huge audiences which the big names now attract.

However, some controversy surrounds the ethics and conduct of live surgery. We wrote in the BJUI previously about some concerns we had and questioning the absolute educational value of these demonstrations. Well known leaders such as Dr Arthur Smith have also voiced concerns about live surgery and in some specialties and some countries, live surgery demonstrations are banned. In response, it has been encouraging to see the European Robotic Urology Society (now an official Section of the EAU), whose annual meeting is a live surgery spectacular, work with others to generate guidelines and ethical standards for the conduct of live surgery at scientific meetings. These will be published in the coming months.

So when it dawned on me that the personal price to pay for fame on reality TV was too high, I resigned myself to a life away from the glamour and fame of reality TV. However, I was very interested when Alex Mottrie and Ben Challacombe invited me to do a live robotic radical prostatectomy for the European Robotic Urology Symposium in London a few months ago. I had only ever done live surgery demonstrations for quite small audiences previously (I had done my karaoke version of American Pie to bigger audiences), and I was somewhat daunted and excited by the prospect of doing live surgery for a big audience, especially one full of the “Gods of Robotic Surgery”. The reality TV star inside me was saying ‘YES! I AM GOING TO BE A STAR!!” So I said yes. And the nerves started soon after. By the time it got to the opening morning of ERUS (in stunning post-Olympics London), I was pretty anxious. The case was straight-forward and I had done hundreds already, so why was I nervous? Well the audience was big (>800), and they looked blood-thirsty – I could feel them licking their lips at the prospect of something going badly wrong. I knew that a few of the “good luck mate” wishes that I had received that morning could be interpreted as “I hope you don’t hurt your head when you fall off your pedestal”. And the big guys were all over the place. The live surgery roll included Vip Patel, Richard Gaston, Alex Mottrie, Prokar Dasgupta, James Porter, Ronney Abaza, Mike Stiefleman, Ashok Hemal and Peter Wiklund. Francesco Montorsi was in the operating room next door and we would be operating in parallel. It was somewhat daunting. Even the stars looked nervous before going live with their surgery, some were even quite temperamental as the stress builds, but when they go live to the convention centre, they put on their “TV-face” and the show begins – all sweetness and charm. Quite a show.

Before live surgery at Guy’s

In the “Green Room” before live surgery at Guy’s Hospital in London for ERUS 2012: Ken Palmer, Geoff Coughlin, Jim Porter, Vip Patel, Declan Murphy, Francesco Montorsi and Declan Cahill

For me, I figured out that the reason I was nervous was that I did not want to make a mess of it in front of a big audience. Human nature has a vain streak to it, and much as I am embarrassed to admit it, I realised that some of my anxiety was just that – I wanted to look and sound good on the big screens. There – I’ve said it! Something certainly added a different stress to the normal pressure of wanting to do an excellent job for your patient, and I expect that even the highly experienced live surgery stars who feature at these meetings do feel this extra pressure. Especially when things get a little sticky or you cause some bleeding and someone at the other end is asking “why did you do that?” Thankfully my case went nicely and my patient has done very well – details to be presented at next year’s ERUS as part of their new guidelines which will see feedback from all cases from the previous Symposium – an excellent initiative.

Doing robotic radical prostatectomy at ERUS 2012

Doing robotic radical prostatectomy at ERUS 2012

Doing robotic radical prostatectomy at ERUS 2012

So for now, the reality TV star in me has been sated and life goes on. Although I did hear there may be a new reality TV series in Australia for amateurs who fancy themselves as crocodile hunters. I wonder would she let me do that….

Declan Murphy
@declangmurphy

 

Declan Murphy is Honorary Clinical Associate Professor at the Department of Surgery, University of Melbourne, St Vincent’s Hospital and Director of Robotic Surgery at the Peter MacCallum Cancer Centre. He had previously been consultant urological surgeon at Guys & St Thomas’ NHS Foundation Trust in London.

 

Comments on this blog are now closed.

 

© 2024 BJU International. All Rights Reserved.